Morepen Laboratories Ltd
NSE:MOREPENLAB

Watchlist Manager
Morepen Laboratories Ltd Logo
Morepen Laboratories Ltd
NSE:MOREPENLAB
Watchlist
Price: 37.71 INR -1% Market Closed
Market Cap: 20.7B INR

Wall Street
Price Targets

MOREPENLAB Price Targets Summary
Morepen Laboratories Ltd

There are no price targets for MOREPENLAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Morepen Laboratories Ltd Competitors:
Price Targets
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
3% Upside
170900
Dong-A ST Co Ltd
31% Upside
4502
Takeda Pharmaceutical Co Ltd
2% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
16% Upside
ELAN
Elanco Animal Health Inc
6% Upside
AFT
AFT Pharmaceuticals Ltd
15% Upside
OGI
OrganiGram Holdings Inc
55% Upside
COLL
Collegium Pharmaceutical Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Morepen Laboratories Ltd

For the last 13 years the compound annual growth rate for Morepen Laboratories Ltd's revenue is 15%. The projected CAGR for the next 7 years is -15%.

15%
Past Growth
-15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Morepen Laboratories Ltd

The compound annual growth rate of Morepen Laboratories Ltd's operating income for the next 7 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Morepen Laboratories Ltd

The compound annual growth rate of Morepen Laboratories Ltd's net income for the next 7 years is -14%.

N/A
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOREPENLAB's stock price target?
Not Available

MOREPENLAB doesn't have any price targets made by Wall Street professionals.

What is Morepen Laboratories Ltd's Revenue forecast?
Projected CAGR
-15%

For the last 13 years the compound annual growth rate for Morepen Laboratories Ltd's revenue is 15%. The projected CAGR for the next 7 years is -15%.

What is Morepen Laboratories Ltd's Operating Income forecast?
Projected CAGR
-10%

The compound annual growth rate of Morepen Laboratories Ltd's operating income for the next 7 years is -10%.

What is Morepen Laboratories Ltd's Net Income forecast?
Projected CAGR
-14%

The compound annual growth rate of Morepen Laboratories Ltd's net income for the next 7 years is -14%.

Back to Top